| Market revenue in 2024 | USD 120.8 million |
| Market revenue in 2030 | USD 164.4 million |
| Growth rate | 5.4% (CAGR from 2025 to 2030) |
| Largest segment | Respiratory |
| Fastest growing segment | Gastrointestinal |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Respiratory, Gastrointestinal, Central Nervous System, Other Types of Syndromes (cUTI and STDs) |
Publish Date: Mar 11, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| QIAGEN | View profile | - | - | - |
| Becton, Dickinson & Company | View profile | - | - | - |
| Luminex Corp. | View profile | - | - | - |
| Applied BioCode | View profile | 11-50 | Santa Fe Springs, California, United States, North America | apbiocode.com |
| Curetis | View profile | 101-250 | Holzgerlingen, Baden-Wurttemberg, Germany, Europe | www.curetis.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Syndromic Multiplex Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Respiratory was the largest segment with a revenue share of 34.11% in 2024.
Horizon Databook has segmented the U.K. syndromic multiplex diagnostics market based on respiratory, gastrointestinal, central nervous system, other types of syndromes (cuti and stds) covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Syndromic Multiplex Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Syndromic Multiplex Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
